BC
ATNM icon

BIT Capital’s Actinium Pharmaceuticals ATNM Stock Holding History

BIT Capital’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-89,668
Closed -$664K – 114
2024
Q2 		$664K Hold
89,668
– – 0.05% 90
2024
Q1 		$702K Buy
89,668
+69,892
+353% +$449K 0.05% 99
2023
Q4 		$100K Buy
+19,776
New +$102K 0.01% 90
2021
Q4 		– Sell
-14,100
Closed -$125K – 146
2021
Q3 		$125K Hold
14,100
– – 0.01% 91
2021
Q2 		$112K Hold
14,100
– – 0.01% 84
2021
Q1 		$107K Buy
+14,100
New +$120K 0.01% 63

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

BIT Capital's ATNM Position: Q3 2024 in Review

BIT Capital sold out of Actinium Pharmaceuticals (ATNM) in Q3 2024, closing a stake of 89,668 shares — an estimated $664K sold.

BIT Capital first reported a position in ATNM in Q1 2021 and held it in 6 quarters. The position peaked at $702K in Q1 2024. 72 funds tracked by Wall St. Rank hold ATNM as of Q3 2024.

  • BIT Capital reported no remaining Actinium Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • BIT Capital sold 89,668 Actinium Pharmaceuticals shares in Q3 2024, an estimated $664K.
  • BIT Capital first reported a position in Actinium Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • BIT Capital's Actinium Pharmaceuticals position peaked at $702K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2024.

Based on BIT Capital's 13F filing for Q3 2024, filed 12 Feb 2025.